Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61